Joseph Walker
We have numerous vaccines, but still no effective COVID treatments. Why not?
Nearly a year and a half into the pandemic, researchers are still struggling to find effective, easy-to-use drugs to treat ...
For decades, scientists struggled to find a treatment for one of the most common lung cancer mutations. Amgen has won US approval for the first drug targeting the KRAS variant
[A new] drug, called Lumakras, was approved [May 28] to treat a portion of lung cancer patients with a particular ...
Long-time pharma rivals unite to fight a common enemy: COVID-19
In the age of Covid-19, old adversaries are uniting around a common enemy: the new coronavirus. Their nascent partnership is ...
Infographic: From vaccines to drugs, chasing ‘silver bullets’ targeting the fast-moving coronavirus
For drug companies, there is suddenly only one priority: the coronavirus. More than 140 experimental drug treatments and vaccines for ...
Can Myriad Genetics maintain hold on breast cancer tests two years after loss of patents?
Myriad Genetics Inc., used a patent-protected monopoly to become one of the most successful and controversial DNA testing companies in the world ...
Myriad BRCA test Medicare reimbursement rate (and price?) cut
Medicare reimbursement rates for a popular genetic breast cancer test will drop by half in the new year as a ...